Your institution may have access to this item. Find your institution then sign in to continue.
Title
Monitoring Tumor Response to Antiangiogenic Sunitinib Therapy with <sup>18</sup>F-Fluciclatide, an <sup>18</sup>F-Labeled α<sub>V</sub>β<sub>3</sub>-Integrin and α<sub>V</sub>β<sub>5</sub>-Integrin Imaging Agent.